Status:
RECRUITING
Precision Diagnosis and Risk Stratification of Rare Cardiomyopathies Based on Novel Cardiac Magnetic Resonance Techniques
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Collaborating Sponsors:
Peking Union Medical College Hospital
Beijing Anzhen Hospital
Conditions:
Danon Disease
Fabry Disease
Eligibility:
All Genders
Brief Summary
What is this study about? This research is focused on improving the care for people with rare heart muscle diseases, known as rare cardiomyopathies. These are uncommon conditions where the heart muscl...
Detailed Description
Study Objective: This study aims to validate and apply novel Cardiac Magnetic Resonance (CMR) imaging biomarkers to improve the diagnostic precision and risk stratification of rare cardiomyopathies (...
Eligibility Criteria
Inclusion Criteria:
- Patients who have received a cardiac magnetic resonance examination since 2010 and have a suspicion of rare cardiomyopathy.
Exclusion Criteria:
- Severe arrhythmia;
- Severe primary cardiac valvular disease;
- Refuse to participate in the study.
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07336394
Start Date
January 1 2010
End Date
December 30 2030
Last Update
January 21 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, China, 100037